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Abstract
Oncolytic viruses are viruses that specifically infect cancer cells and kill them, while leaving healthy cells largely intact. Their
ability to spread through the tumor makes them an attractive therapy approach. While promising results have been
observed in clinical trials, solid success remains elusive since we lack understanding of the basic principles that govern the
dynamical interactions between the virus and the cancer. In this respect, computational models can help experimental
research at optimizing treatment regimes. Although preliminary mathematical work has been performed, this suffers from
the fact that individual models are largely arbitrary and based on biologically uncertain assumptions. Here, we present a
general framework to study the dynamics of oncolytic viruses that is independent of uncertain and arbitrary mathematical
formulations. We find two categories of dynamics, depending on the assumptions about spatial constraints that govern that
spread of the virus from cell to cell. If infected cells are mixed among uninfected cells, there exists a viral replication rate
threshold beyond which tumor control is the only outcome. On the other hand, if infected cells are clustered together (e.g.
in a solid tumor), then we observe more complicated dynamics in which the outcome of therapy might go either way,
depending on the initial number of cells and viruses. We fit our models to previously published experimental data and
discuss aspects of model validation, selection, and experimental design. This framework can be used as a basis for model
selection and validation in the context of future, more detailed experimental studies. It can further serve as the basis for
future, more complex models that take into account other clinically relevant factors such as immune responses.
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Introduction
Oncolytic viruses are live replicating viruses that selectively
infect cancer cells and kill them [1–14]. Healthy cells are largely
spared. The idea is to inoculate the virus into a cancer patient, and
let the virus spread throughout the tumor, thereby driving it into
remission. Selectivity for cancer cells occurs because cancer cells
tend to lack important genes that normally shut down the
replication cycle of the virus. For example, the adenovirus ONYX-
015 has been engineered such that it only replicates in p532/2
cells, a characteristic of many cancers [10]. Certain animal viruses
by chance have the ability to replicate in human cancer cells, while
healthy human cells are not permissive. An example is Newcastle
disease virus, which can replicate in tumor cells that lack
interferons [7,15]. In general, a wide array of viruses is being
explored as potential oncolytic viruses.
Oncolytic viruses have shown promising results in clinical trials
[16]. Cancers have been found to respond to treatment, leading to
tumor remission in some cases. Consistent and sustained
eradication or control of cancers has, however, been very difficult
to achieve. This is caused in part by our lack of understanding
regarding the dynamics that underlie the spread of oncolytic
viruses through tumors. Without such a rigorous understanding,
much of the work is based on trial and error. In such scenarios,
mathematical models can be very useful to complement empirical
work. Mathematical analysis allows us to see the whole spectrum
of possible outcomes, and provides a means to logically suggest
ways to optimize treatment. Limited mathematical analysis of
oncolytic virus therapy has been performed in the past [17–21].
This work is largely qualitative in nature, examining how variation
in viral and host parameters influences the outcome of treatment.
For example, it has been suggested that maximizing the virus-
induced rate of tumor cell killing is not going to lead to the best
treatment outcomes. Instead, an intermediate and optimal rate of
virus-induced cell death optimizes treatment success [17,18]. This
work was based on the analysis of the equilibrium properties of the
model. That is, the lower the total number of cancer cells that
remain as the dynamics converge to steady state, the better the
predicted outcome of therapy.
While such steady state analysis can provide some valuable
qualitative insights, it has limitations. The main problem is that in
such infection dynamics models, the population of cells and viruses
can show extensive oscillations before converging to a steady state.
During these oscillations, the populations of cells and viruses can
potentially go extinct, and the system might never reach
equilibrium. Therefore, it is important to understand these
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cancer cell population is driven extinct.
This paper aims to analyze these dynamics in detail in an
attempt to provide a more realistic description of oncolytic virus
dynamics. This is a difficult task because these infection dynamics,
and in particular the occurrence of population oscillations, can be
dependent on particular details of the models that are of a
biologically uncertain nature. To address this issue, we avoid
concentrating on a particular model, but take a more general
approach. Through specific restrictions about biological assump-
tions, we analyze a class of mathematical models that aim to
describe viral spread through a tumor in different settings. We seek
to determine conditions under which the virus is successful at
eliminating the tumor, and the conditions when virus therapy fails.
In order to underline the insights that we gain from this general
framework, we also consider specific models that are examples of
the general framework. This modeling framework provides the
basis for experimental validation and testing procedures, which
will allow us to accurately predict the time course of cells and
viruses at least in relatively simple scenarios, such as in vitro
experiments or simple in vivo scenarios. In this context, we fit the
models to previously published experimental data and discuss
implications for model testing, model selection, and experimental
work. A predictive model of a complex in vivo situation (e.g.
including immune responses) will obviously be more difficult to
attain, but can arise from a thorough understanding of the simpler
in vitro scenario that we examine here.
Results
The modeling framework
We will model the dynamics of oncolytic virus replication by
ordinary differential equations that describe the development of
the average population sizes of cells and viruses over time. This
approach is based on very well established mathematical models
that describe the general dynamics of virus spread both in vivo and
on an epidemiological level [22,23]. Instead of considering a
specific model, however, we will take a generalized approach and
consider a class of models. The general modeling framework used
in our study is as follows. We take into account two populations:
uninfected tumor cells, x; and infected tumor cells, y. The
population of free viruses is not modeled explicitly. Because the
turnover of free viruses is much faster than that of infected cells, we
simply assume that the free virus population is in a quasi-steady
state and proportional to the number of infected cells. The basic
model is given as follows:
_ x x~xF x,y ðÞ {byG x,y ðÞ , ð1Þ
_ y y~byG x,y ðÞ {ay: ð2Þ
The function F describes the growth properties of the uninfected
tumor cells, x, and the function G describes the rate at which
tumor cells become infected by the virus. These functions are
unknown and can potentially take a variety of forms, which will be
discussed below. The coefficient b in front of the infection term
represents the infectivity of the virus. Finally, virus-infected cells
die with a rate ay. We will not include immune responses in our
considerations. While immune responses will certainly be an
important factor for oncolytic virus dynamics in vivo, our goal is to
first understand those dynamics in a simpler setting without the
presence of immune responses. These models would be suitable to
describe the growth of oncolytic viruses in relatively simple in vitro
or in vivo settings. Once an understanding of such simple systems
has been achieved, additional biological complexities (such as the
presence of immune responses) can be added to the model.
This class of models is characterized by the existence of
equilibria, the number and nature of which depends on the tumor
growth term F and the infection term G. In the most general sense,
the equilibria of the system are defined by the following two
equations:
xF x,y ðÞ ~ay, ð3Þ
Gx ,y ðÞ ~
a
b
: ð4Þ
We will explore the equilibria and their properties depending on
the tumor growth term, F, and the infection term, G.
The term F reflects the growth properties of an uninfected
tumor. It comprises both division and death rates. The simplest
assumption that can be made about the term F is that growth is
exponential (or, more precisely, the division and death happen
according to an exponential law, and the division rate is higher
than the death rate). While this can be true during early stages of
tumor growth, tumor growth certainly deviates from an exponen-
tial pattern at larger sizes for a variety of reasons, for example
space or nutrient limitations. Therefore, more complicated tumor
growth terms involving some form of saturation must be
considered [24]. In this respect, we can distinguish between two
basic scenarios: First, while the rate of tumor growth saturates and
slows down at higher tumor sizes, the tumor has the potential to
keep growing towards infinity. Growth would stop once the tumor
has reached a lethal size. Second, it can be assumed that growth
not only slows down, but comes to a halt as the tumor size reaches
a critical level, which can be called the carrying capacity of the
tumor. This could happen when the division rate equals the death
rate of the cells.
Regarding the infection term, the assumption used most often in
mathematical models is that it is directly proportional to the
number of infected and uninfected cells [25,26]. This, however,
assumes mass action or perfect mixing of populations, which is
unrealistic, especially in the context of tumors. Instead, virus
spread is likely to be slower, limited by spatial constraints. Since
the virus released from one infected cell cannot reach all
susceptible tumor cells in the population, the infection rate must
be a saturating function of the number of susceptible tumor cells.
Similarly, not all infected cells present in the population will be
able to contribute to the generation of newly infected cells, for
example if they are spatially separated from susceptible cells.
In the following section, we will define different classes of
infection terms that have biologically reasonable characteristics,
and investigate how they influence the properties of the model.
These are based in part on mathematical work done in the context
of infectious disease epidemiology [25,26]. Subsequently, we will
examine how changing the tumor growth term influences the
model predictions.
Different classes of infection terms and their properties
Let us consider two different classes of viral growth, see
figure 1(a,b). Tumor-virus systems belonging to class I are
characterized by the following property: if the number of
uninfected tumor cells is high relative to the number of infected
cells, virus growth does not slow down as the number of infected
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interpreted as virus replication in a non-solid tumor where cells
mix relatively freely. In other words, infected cells are not clustered
together in a mass but are interspersed among uninfected cells.
This is shown schematically at the top of figure 1(a) (the white
circles represent uninfected cells, and the black circles - infected
cells). In this case, if the number of uninfected cells is relatively
large, then every infected cell is likely to be surrounded by
uninfected cells to which the virus can be passed on. Alternatively,
a similar picture can be achieved by a very high motility of the
virus. In either case, all infected cells contribute to viral spread and
growth is exponential. We call this ‘‘fast virus spread’’. On the
other hand, with tumor-virus systems that belong to class II, the
virus growth rate decreases as the number of infected cells rises,
even if the number of uninfected cells is very large. The biological
interpretation is that infected tumor cells are clustered together,
figure 1(b). This can occur in solid tumors, which typically show a
high degree of spatial arrangement. In this case, as the number of
infected tumor cells increases, most infected cells will be
surrounded by other infected cells and not by uninfected cells.
Hence, they cannot pass on the virus and cannot contribute to
virus spread. Only cells at the periphery of the infected cell mass
have uninfected cells in the neighborhood and can contribute to
new infection events. We refer to this model of infection as ‘‘slow
virus spread’’.
Next let us connect this classification with the mathematical
model, and in particular, with the infection term, byG(x,y). The
function G(x,y) is related to the proportion of the total population
of the infected cells which participates in the infection process. It is
plotted in figure 1 as a function of the number of tumor cells, x,
and we examine the shape of these plots. Let us take a closer look
at the schematic at the top of figure 1(b). Because of the
geometrical arrangement of the cells in this case, only the infected
cells on the surface of the black core will be able to infect other
cells (it is 6 out of the 7 cells in the smaller colony presented). Now,
let us increase the system size, such that the number of infected
and uninfected cells grows in the same proportion. Again, only the
infected cells close to the surface of the infected core will
participate in the infection process. However, now the proportion
of the surface cells is much smaller (11 out of 20 cells). As the size
of the system increases, the proportion of such ‘‘active’’ cells (that
is, cells capable of infecting other cells) decreases. This is what is
depicted in the graph in figure 1(b), where the function G(x,y)
declines following the peak. (For very small system sizes, the
proportion of cells participating in infection is formally zero
because of the lack of uninfected cells, therefore the graph of the
function G starts at zero, reaches a peak, and then declines for high
values of x). Next, we take a look at the cell arrangement at the top
of figure 1(a). Here, the populations are well-mixed, and as the
system grows, a constant fraction of infected cells will be able to
infect new cells. This is reflected in the corresponding graph of
G(x,x/a), which reaches an asymptote and does not decline. In
Table 1 we list several examples of fast and slow growth laws.
In general, we can prove that the two scenarios above are the
only possible outcomes, given the biological requirements imposed
on the function G.A sx increases, this function increases, and can
either approach zero or a nonzero level. If it approaches a non-
zero level, this does not necessarily need to occur via a monotonic
approach to the asymptote. It is possible that the function G first
increases, peaks, and then converges to a non-zero asymptote. For
intermediate values of x the function G may have a more
complicated structure than that shown in figure 1, but in the
absence of any biological evidence of that it is a safe bet to assume
the simplest shape with a minimal number of local extrema.
Figure 1. Two classes of virus growth captured by the mathematical models. (a) According to class I or fast virus growth, virus growth is
exponential as long as the number of uninfected cells is significantly larger than the number of infected cells. This can correspond to a high degree of
mixing between infected and uninfected cells. As the virus population grows, the number of cells that contribute to virus spread remains constant
because most infected cells will have an uninfected cell in their vicinity. (b) According to class II or slow virus growth, virus growth slows down and
saturates as the virus population increase in size, even if the number of uninfected cells is relatively large. This can correspond to spatial clustering of
the infected cells. Only infected cells at the surface have uninfected cells in their neighborhood and can thus contribute to virus transmission. As the
number of infected cells rises, the number of ‘‘active’’ cells that can contribute to virus transmission declines.
doi:10.1371/journal.pone.0004271.g001
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about the behavior of the biological system? It turns out that the
function G is essential in determining the number and the stability
properties of the equilibria of the system, and thus it will help us
reason about long-term predictions on the treatment outcome.
Equations (3–4) can be combined in a single equation,
Gx ,yx ðÞ ðÞ ~a=b, ð5Þ
where the function y(x) is a relationship between the number of
infected and uninfected cells at equilibrium as the total system size
grows; it is obtained from equation (3) and depends on the exact
rate of cancer growth, F. If the cancer growth is exponential
(F=1), we have y(x)=x/a, that is, at equilibrium, the infected cells
comprise a fixed fraction of uninfected cells. Thus the function
G(x,x/a) depicted in figure 1 is just the left hand side of the
equation for the equilibria, equation (5). The right hand side is
represented by horizontal dashed lines, whose level decreases with
the viral replication rate b. The number of intersections
corresponds to the number of equilibria in the system.
We can see that the two graphs in figure 1 exhibit different
numbers of equilibria. First we consider figure 1(a), fast virus
spread. In this case, the model always contains a parameter region
in which exactly one equilibrium exists. If the viral replication rate,
b, lies below a threshold (b,bc) then no equilibrium exists. If the
viral replication rate lies above that threshold, the following is
observed. As shown in figure 1(a) exactly one equilibrium is found.
In other cases, it is possible that there are two or more equilibria
for intermediate viral replication rates. (For example, if the
function G(x,x/a) first rises and achieves a maximum before
descending to its horizontal asymptote, or if it goes through a
number of local extrema before approaching a horizontal
asymptote.) The most important universal feature in all fast
growth scenarios is that for sufficiently high values of b, there is
exactly one equilibrium. Next, consider Figure 1(b), slow virus
spread. Again, for an equilibrium to exist, the viral replication rate
needs to lie above the threshold b.bc. If this is the case, the system
is always characterized by the presence of not one, but two
equilibria. Again, in some cases, it is possible that the intermediate
values of b correspond to more than two equilibria.
The biological interpretation of this analysis is as follows. We
saw that for both modes of infection, if the values of the viral
replication rate b are small, no equilibria exist. This translates into
an uncontrolled cancer growth. This is an intuitive result: for low
viral replication rates, treatment is impossible. A less intuitive
result is connected with the number of equilibria once b is above
its threshold value.
The cancer-virus system displays a fundamentally different
behavior depending on whether it is characterized by one or two
equilibria. If there is only one equilibrium, then the dynamics will
be governed by the properties of this equilibrium only. Because the
number of tumor cells is relatively low at this equilibrium, this
outcome corresponds to containment of the tumor by the virus.
For convenience, we call this internal equilibrium EI. On the other
hand, the situation is more complicated if the system is
characterized by two equilibria. The first equilibrium, at which
the number of tumor cells is lower, is again the internal
equilibrium, EI, and can be interpreted as containment of the
tumor by the virus. The second equilibrium can be shown to be an
unstable saddle node equilibrium, call it ES. The presence of the
saddle equilibrium means that the dynamics are qualitatively
different depending on the initial conditions. If the initial number
of tumor cells is relatively low and close to the internal
equilibrium, then the dynamics are governed by this internal
equilibrium, EI, leading to a degree of tumor control. If the initial
number of tumor cells is higher and around or above the saddle
node equilibrium ES, then the number of tumor cells increases in
an uncontrolled fashion. Hence, in this regime, uncontrolled
cancer growth is always a possible outcome.
We conclude that our biologically defined modes of virus spread
correspond to very different mathematical properties. Models of class
I (fast virus spread) contain a parameter region (of high enough b)i n
which only a single equilibrium is observed. In this case, the model
contains a parameter region in which uncontrolled cancer growth is
impossible. Models of class II (slow spread) never have only one
equilibrium and the saddle node equilibrium ES is present whenever
the internal equilibrium EI exists. In this class of models, no matter
how high b is, uncontrolled cancer growth is always a possibility.
Effect of the tumor growth term
For the purposes of classification of the virus spread terms, we
looked at the changes in G as the number of infected and uninfected
cells grew in the same proportion. This led to a direct evaluation of
the number of equilibria for exponential cancer growth (F=1).
While mathematically the simplest scenario, exponential growth is
an unrealistic assumption, because the growth of cells is bound to
saturate as the tumor grows. Our methods allow to study any
reasonable cancer growth law in a very natural way.
Let us model a slow-down of the tumor growth rate as the
number of tumor cells increases. This can be done in two different
ways. On the one hand, we can assume that while tumor growth
slows down, it never stops, such that the tumor can grow towards
infinity over time. That is, there is no upper limit to the number of
tumor cells; in practical terms growth will stop when the organism
dies. An example is what we call ‘‘surface growth’’, where only the
cells around the surfaceof the tumor can give rise to viable daughter
cells and can contribute to tumor spread. This can apply to solid
tumors that have a high degree of spatial structure. Surface growth
in 2D and 3D are listed in Table 2. The parameter g determines the
tumor size at which saturation comes into play. Another possibility
that falls into this category is that the rate of tumor growth becomes
linear as the number of tumor cells increases. In this case, tumor
growth is even slower; we refer to it as ‘‘linear growth’’.
On the other hand, it is possible that there is a natural limit or
carrying capacity, W, that limits tumor growth [27]. Thus, we will
assume that growth slows down and eventually stops as the
number of tumor cells increases. This can occur in a variety of
ways. Tumor growth can be exponential until the number of cells
approaches carrying capacity and the rate of tumor cell growth
Table 1. Examples of different virus spread terms, G(x,y).
G(x,y) Law of virus spread
ez1 ðÞ x= xzyze ðÞ Fast (frequency dependent)
x
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
xzyze1
p ﬃﬃﬃ
x
p
z
ﬃﬃﬃ
y
p
ze2
   Fast
x
xy1=3ze
Slow
e1z1 ðÞ e2z1 ðÞ x
xze1 ðÞ yze2 ðÞ
Slow
x
ﬃﬃﬃﬃﬃﬃ
xy
p
ze1
   ﬃﬃﬃ
x
p
z
ﬃﬃﬃ
y
p
ze2
   Slow
x
ﬃﬃﬃ
x
p
yzc ðÞ zxze
Slow
doi:10.1371/journal.pone.0004271.t001
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growth term (see Table 2) [27]. Alternatively, we can assume that
tumor growth first saturates according to the surface growth or
linear growth patterns described above, and only reaches the
carrying capacity once the tumor has grown to a significantly
larger number of cells. Another example of a growth with a
carrying capacity is a Gompertzian type growth [27], Table 2.
As mentioned before, the term F reflects implicitly both division
and death properties of uninfected tumor cells. For example, an
exponential growth is characterized by a net expansion rate
resulting from exponential division and death processes. The
logistic growth is a consequence of saturation of the division rate
while the (exponential) death rate remains constant. In fact, any
process with a sub-exponential division rate and an exponential
death will be characterized by a finite carrying capacity. On the
other hand, an unlimited (but saturated) growth (such as surface
growth) implicitly includes death which happens slower than
exponentially. If we were to add an exponential death term to a
surface growth, it would lead to a limited growth with a carrying
capacity. Our framework includes all these and any other
reasonable functional forms of cellular growth.
In the following, we will examine the effect of different types of
tumor growth terms on the properties of the model. We will do this
first in the context of the faster virus infection terms that belong to
class I, and then in the context of the slower infection terms that
belong to class II. Note that our analysis is quite general and the
particular growth laws listed in Table 2 are merely an illustration;
the results are not restricted to these particular growth laws.
Effect on fast virus growth. With this class of virus infection
term, we found that in the context of exponential tumor growth,
G(x,y(x)) with y(x)=x/a approaches a nonzero asymptote for large
values of x (note that it can either rise monotonically to the
asymptote, or first go through one or more local maxima before
declining towards the asymptote). In either case, for any
equilibrium to exist, the viral replication rate needs to lie above
a threshold b.bc, and there exists a parameter region
(characterized by values of b greater than a threshold) in which
only the internal equilibrium EI is present. In this parameter
region, tumor control is the only outcome.
Introducing saturated tumor growth (or changing the function F
in any way) will lead to a different functional form of y(x) in
equation (5). A universal feature is that any tumor growth slower
than straight exponential growth will lead to smaller values of y(x)
and thus to higher values of G. Therefore, as a result of tumor
growth saturation, the asymptote becomes higher for slower tumor
growth terms. This means that only the internal equilibrium EI
can exist, as with exponential growth. The only difference lies in
the viral replication rate threshold beyond which this equilibrium
can exist and beyond which tumor control is possible. The slower
the tumor growth, the lower the viral replication rate threshold
required for virus-mediated control.
If we assume saturated but limited tumor growth (i.e. growth
stops at carrying capacity W), then the picture is similar for the
most part, with one difference. After the term G(x,y(x)) has
approached the asymptote, the curve G takes an upward turn in
the vicinity of x=W, i.e. when the number of cells approaches
carrying capacity. This means that the model acquires an
additional equilibrium, which corresponds to the cancer growing
to its carrying capacity W. In the systems with unrestrictive
growth, this was equivalent to unlimited growth of the cell
population to infinitely large sizes. This is illustrated with the
dotted line in Figure 2(a). We can see that for x%W, the curves for
limited and unlimited growth laws look identical, and near the
carrying capacity W they deviate.
So far, we have concentrated on the case where G(x,y(x))
increases monotonically towards an asymptote. Alternatively, the
term G(x,y(x)) can rise to a peak and then decline toward a non-
zero asymptote. In this case, including saturation into the tumor
growth term F(x,y) leads to similar consequences. However, the
hump in the function can disappear, eliminating any parameter
region in which both equilibria can exist. In other words, with
slower tumor growth, there is no parameter region anymore in
which the tumor can escape the effect of the virus and grow out of
control. Whether this occurs or not depends on the relative size of
the two spatial scales involved. The first scale is defined by the
tumor size at which the virus infection function G saturates and
peaks in the context of exponential growth; this is entirely
dependent on the properties of the viral growth term. Let us call
this scale sv, where the subscript refers to ‘‘viral’’. The second scale
is given by the colony size at which the tumor growth law starts to
deviate from exponential; we will call this scale st (where the
subscript refers to ‘‘tumor’’). When xt#sv, the asymptotic value of
G becomes sufficiently large such that the hump disappears. The
disappearance of the hump makes treatment easier, and this
occurs if tumor growth slows down before virus growth does.
Effect on slow virus growth. Here, we assume slower virus
growth terms that belong to class II. In the context of exponential
growth, the function G(x,y(x)) first increases, and then declines
towards zero. This means that if equilibria exist, both the internal
equilibrium EI and the saddle node equilibrium ES are aways
present. Consequently, the possibility always exists that the tumor
can out-run the virus infection and grow uncontrolled. Taking into
account saturated tumor growth has the following effect
(Figure 2(b)). (i) The function G can remain qualitatively the
same; that is, it rises to a peak and then declines towards zero. (ii)
Alternatively, the picture can change such that it does not decline
towards zero, but towards a non-zero asymptote, while remaining
a one-humped function. (iii) Finally, the picture can change
further such that the function G increases monotonically towards
an asymptote. Which outcome is observed depends on the exact
nature of the functions F and G and also the relative size of the two
spatial scales involved: the tumor size at which the virus infection
term G saturates and peaks (sv), and the size st at which the pattern
of tumor growth starts to deviate from exponential. Lowering the
value of st relative to sv shifts the outcome from scenario (i) to (iii).
As the value of st becomes similar to the value of sv, the model
contains parameter regions in which only the internal equilibrium
EI exists and in which uncontrolled tumor growth is impossible. If
st%sv, then the hump in the function G disappears, and the saddle
node equilibrium ES is never present. In this case, virus-induced
tumor control is the only outcome, and uncontrolled tumor
growth cannot be observed. In biological terms, saturation of
Table 2. Examples of different tumor growth terms, F(x+y).
F(x+y) Growth Law
1 Exponential
g= gzxzy ðÞ Linear
g= gzxzy ðÞ ðÞ
{1=2 Surface growth in 2D
g= gzxzy ðÞ ðÞ
{1=3 Surface growth in 3D
1{ xzy ðÞ =W Logistic
log
Wzg
xzyzg
log
Wzg
g
   {1 Gompertzian
doi:10.1371/journal.pone.0004271.t002
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These arguments apply to all saturated tumor growth scenarios.
With saturated but unlimited tumor growth, the function G
approaches an asymptote for large tumor sizes x. For tumor
growth that is limited by a carrying capacity W, the function G
eventually deviates from the asymptote and rises again, indicating
the presence of an equilibrium that describes tumor growth
towards carrying capacity rather than towards infinity. Lowering
the carrying capacity W has the same effect as lowering the
parameter st that determines the tumor size at which growth starts
to saturate: it shifts the outcome from scenario (i) to (iii).
Summary of model properties
In summary this analysis has provided the following insights.
We examined two types of infection terms and found that they
strongly influence the dynamics of oncolytic virus spread. In the
first class of models, virus spread was fast because infected cells are
mixed among uninfected cells. In this case, tumor control is always
observed if the viral replication rate lies above a threshold. In these
parameter regions, loss of tumor control is not observed. In the
second class of models, virus spread was assumed to be slow,
because infected cells are clustered together in space. In this
situation, the model can be characterized by bistability. If the
initial number of tumor cells lies below a threshold, tumor control
is observed. If the initial number of tumor cells lies above this
threshold, uncontrolled tumor growth is observed. If tumor growth
only saturates at high numbers of tumor cells or not at all, then
uncontrolled tumor growth is always possible in parameter regions
in which tumor control is possible. If tumor growth saturates at
lower levels, there are parameter regions in which only the tumor
control outcome is observed and in which uncontrolled tumor
growth is not possible. If tumor growth saturates at even lower
levels, then the bistability and the dependence on initial conditions
vanishes completely.
Properties of the internal equilibrium
The above analysis concentrated on the equilibria. By
examining which equilibria exist under different conditions, we
can obtain information about the ability of the virus to control the
cancer, and about the possibility that the cancer grows despite the
presence of the virus. If the dynamics are governed by the internal
equilibrium EI, then the virus keeps the tumor cell population at
relatively low levels and prevents uncontrolled tumor growth. We
have discussed the conditions under which this can be achieved
and interpreted these conditions from a biological angle. If the
virus does control the tumor, however, additional questions arise.
The virus can either control a persisting tumor at low levels, or the
virus can drive the tumor cell population extinct.
Because we are considering ordinary differential equations that
describe the average behavior of the cell and virus populations,
true extinction cannot occur in this model. The number of cells
can, however, drop to very low levels. If the average number of
cells is below one, we can assume that tumor extinction is a likely
event. Therefore, if the number of tumor cells at equilibrium lies
below one, we can say that the virus is likely to drive the tumor
extinct. However, even if the equilibrium number of cells lies
above one, the tumor cell population can still go extinct during
oscillatory dynamics that can occur before the dynamics reach
equilibrium. Therefore, we need to understand the properties of
the internal equilibrium in more detail. We will examine this in the
context of both fast and slow virus growth. We will only assume
saturated tumor growth and not consider straight exponential
tumor growth.
Fast virus growth. One of the most important parameters
that influence the properties of the internal equilibrium is the
replication rate of the virus b. In general, the faster the replication
rate of the virus, the lower is the equilibrium number of tumor
cells. Further, it can be shown that if the viral replication rate b
crosses a threshold, the behavior near the equilibrium becomes
oscillatory. Both promote the eradication of the cancer. In general,
the internal equilibrium can either be stable or unstable,
depending on the particular model under consideration as well
as parameter values.
Let us first consider the case where the equilibrium is stable.
Then we can distinguish between two parameter regions. Denote
the size at which tumor growth slows down and deviates from
exponential by st. In the first parameter region, the value of st is
large compared to a value related to the virus scale, sv (for the exact
Figure 2. The effect of a carrying capacity. The function G(x,y(x)) is plotted for two particular choices of the virus spread law and three different
laws of cancer growth: exponential, surface growth and linear growth. (a) Fast virus spread, G(x,y)=x/(x+y+1) and (b) slow virus spread, G=x/(x+1)/
(y+1). The solid lines correspond to the unlimited cancer growth; the dotted lines - to a growth up to a given size, W. The parameters are: a=1, g=10
and W=10
4.
doi:10.1371/journal.pone.0004271.g002
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region, we observe a viral replication rate threshold, at which the
equilibrium number of tumor cells drops sharply from relatively
high values to values of the order 1 (figure 3a). This replication
rate threshold can be defined for individual models that belong to
this class and defines the condition for cancer eradication. If the
tumor size at equilibrium drops to small values (of the order of 1
cell), stochastic effects are very likely to lead to extinction. This is
further supported by changes in the oscillatory approach to the
equilibrium, which we have investigated in the context of
individual models (figure 3 b). At this viral replication rate
threshold, the amplitude of the initial oscillations can increase
sharply, as can the time it takes for the dynamics to approach the
stable equilibrium (the real part of the eigenvalues of the Jacobian
matrix rapidly approaches zero). Since pronounced oscillations
reduce the number of tumor cells well below one, tumor
eradication is the likely outcome. Note, however, that this drastic
change in the oscillatory pattern is not observed in all models that
belong to this class. The sharp drop in the equilibrium value is,
however, a universal feature of models that belong to this class.
Now assume the other parameter region in which the scale st is
small. In this case, no such viral replication rate threshold exists.
Instead, the equilibrium number of tumor cells declines propor-
tional to the viral replication rate b. Numerical simulation of
individual models, however, indicates that the minimum number
of tumor cells can decline exponentially with an increase in the
viral replication rate, although this could not be proved in general.
Taken together, these findings indicate that in the parameter
regions where virus replication is fast enough such that there is an
oscillatory approach to the equilibrium, tumor eradication is the
likely outcome.
As mentioned above, it is also possible that the internal
equilibrium EI is unstable. In this case, we observe oscillations that
diverge away from the equilibrium if the viral replication rate b is
sufficiently fast. That is the amplitude of the oscillations increases
over time. This is likely to correlate with extinction of the tumor,
Figure 3. (a) The equilibrium number of uninfected cancer cells as a function of the viral replication rate b for fast virus growth. There is a threshold
viral replication rate at which the number of cancer cells drops sharply from relatively high values to values of the order of one. This can be
considered a tumor extinction threshold. (b) Dynamics of the uninfected cancer cells if the viral replication rate lies below (left) and above (right) this
threshold. If the viral replication rate lies below the threshold, limited oscillations are observed that dampen out quickly. If the viral replication rate
lies above the threshold, extensive oscillations are observed that reduce the cancer cell population to very low levels, and that dampen out very
slowly (dampening not observed on time scale shown here). These plots were made by using a specific model from the fast virus growth category,
that is G=(e+1) x/(x+y+e). Note that the transition in oscillations is not a universal feature of all models in this class. Parameters were chosen as
follows: r1=1; a=0.1; e=10; g=10
8; x0=100; y0=10; For (b), b=0.07 and b=0.13, respectively.
doi:10.1371/journal.pone.0004271.g003
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low. This is because the oscillations will reduce the number of
tumor cells well below the equilibrium value over time. Thus we
conclude that for sufficiently large values of b, the cancer will be
driven extinct by the virus through (convergent or divergent)
oscillations.
Slow virus growth. In this case, the tumor size at the internal
equilibrium is again negatively correlated with the viral replication
rate b. Similarly to fast virus growth, the internal equilibrium can
be stable or unstable depending on the individual model and on
the parameter values. The dynamics will be discussed for both
stable and unstable equilibria EI.
If the equilibrium is stable, the approach is again oscillatory if the
viralreplicationrate issufficientlylarge (Figure4aand 5a).Numerical
simulations of individual models indicate that the minimum tumor
size during these oscillations can decline exponentially with the viral
replication rate b,a l t h o u g ha g a i nt h i sc o u l dn o tb ep r o v e di na
general setting. These results indicate, however, that if oscillations are
observeditislikelythatthecancer iseradicatedbythevirus(Figure5).
Note that this assumes that the initial number of tumor cells is
sufficientlysmall such that the population is in the region of attraction
of the internal equilibrium. If this is not the case, the virus fails and
unlimited virus growth occurs because the long-term outcome
depends on the initial conditions as discussed above (Figure 5 a). In
addition to these dynamics, the following can occur (Figure 4(a)).
Assume that the tumor cell population is reduced to low levels during
the initial oscillations, but not to extinction. As the tumor cell
population rises again, it can actually cross over to values larger than
the saddle equilibrium ES.C o n s e q u e n t l y ,t h ec a n c e rw i l lg r o w
uncontrolled and virus therapy will fail.
Figure 4. The phase portrait for a system with a slow virus propagation term. (a) The intermediate equilibrium, EI, is stable (the basin of
attraction is shaded), (b) EI is unstable.
doi:10.1371/journal.pone.0004271.g004
Figure 5. Dynamics in fast virus growth models assuming that the internal equilibrium EI is (a) stable and (b) unstable. (a) If the
internal equilibrium is stable, then the dynamics can converge to this equilibrium via damped oscillation if the initial number of cancer cells is
relatively low. On the other hand, if the initial number of cancer cells is relatively high, then uncontrolled cancer growth is observed. (b) If the internal
equilibrium is unstable, then diverging oscillations are observed. Eventually, these diverging oscillations take the populations beyond the saddle
node equilibrium, leading to unlimited cancer growth. Before that occurs, however, it is most likely that the cancer has been driven extinct in a
stochastic setting because the diverging oscillations drive the tumor size to ever decreasing values. These plots were obtained from a specific model
that belongs to the slow virus growth class, i.e. G~
e1z1 ðÞ e2z1 ðÞ x
xze1 ðÞ yze2 ðÞ . Parameters were chosen as follows: (a) r=1; b=0.8; a=0.5; e1=20; e2=10; g=10
8;
x0=100 and 10,000, respectively; y0=10. For (b) r=1; b=1; a=0.5; e1=10; e2=11$; g=10
8; x0=10; y0=1.
doi:10.1371/journal.pone.0004271.g005
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the following is observed (Figure 4b and 5b). If the viral replication
rate is fast enough, the populations show diverging oscillations
away from the equilibrium (Figure 4b), i.e. the amplitude of the
oscillations increases over time. During these diverging oscillations,
the minimum number of tumor cells declines over time. Hence,
the tumor is likely to hit extinction. Again, there is the possibility
that during the oscillations the tumor cell population crosses over
to values larger than the saddle equilibrium ES. In this case, the
tumor cell population would grow uncontrolled to ever increasing
levels.
To summarize, for slow virus growth oscillations around the
internal equilibrium have the potential to drive the tumor cell
population extinct. However, the bi-stability of this system causes
problems since there is always the possibility that the populations
can escape to large numbers, leading to uncontrolled tumor
growth.
Application of models to experimental data
Here we fit our models to previously published experimental
data and discuss implications for model validation, model
selection, and further experimental work. We examined data
published by [28]. This study considered A549 human lung cancer
nude mouse xenografts, and infected them with the wild-type
adenovirus Ad309 and a mutant virus Ad337 (characterized by a
deletion in the E1b-19kD gene). The resulting dynamics were
investigated under two conditions. (i) Under the first condition, the
cancer cells were used to establish subcutaneous tumors in the
mice. When the tumors reached a certain size, the virus was
injected into the tumor. (ii) In a second scenario, infected cells
were first mixed with uninfected cells, and the mixture was
injected into the mice. The first scenario corresponds to spatially
more restricted virus growth, while in the second scenario there is
a higher degree of mixing between infected and uninfected tumor
cells due to the experimental protocol. For both scenarios, we
fitted models that differ in the infection term G and the tumor
growth term F. We performed non-linear least squares regression,
using standard software. The exact models that were used are
provided in Figures 6 and 7. The parameter estimates obtained for
all fits are tabulated in the Supporting Information S1.
We first fitted the control tumor growth in the absence of the
virus (Figure 6(a)). Both exponential growth and saturated growth
models (logistic, gompertzian, surface and linear, see table 2) were
applied. The saturated growth models fit the data better than
exponential growth. All saturated growth models fit the data well,
the logistic growth yielding the lowest (by a small margin) root
mean square (RMS) error. For convenience, we chose logistic
tumor growth as the basis for analyzing the effect of virus infection.
First, consider experimental condition (i), where the tumor was
allowed to grow in the mice before the virus was inoculated. Only
the wild-type virus Ad309 is considered. In this experiment, tumor
growth was significantly reduced by the virus. However, tumor
size reached a plateau by day 50, despite the persistence of the
virus, leading to the conclusion that the virus failed to eradicate the
tumor cell population. For fitting purposes we considered one fast
and one slow virus spread term, the first and the third in table 1.
Figure 6(b) shows that both a fast and a slow virus growth model
can fit the data. However, extrapolating beyond the experimental
time frame, very different long term outcomes are observed. The
fast model predicts that the tumor remains at relatively low levels,
controlled by the persisting virus infection. With the slow model,
we show two parameter combinations which both fit the data well,
but which are characterized by different long term outcomes. For
one parameter combination (slow 1), damped oscillations are
observed that lead to persistence of both the tumor and the virus at
relatively low levels. For the second parameter combination (slow
2), the tumor cell population escapes control and grows to high
levels. The virus population persists at low and ineffective levels
Figure 6. (a) Data on the growth of A549 human lung cancer nude mouse xenografts in the absence of the virus [28]. Different tumor growth
models were fitted, see Table 2. The parameter values and the root mean square values are summarized in the Supporting Information S1. The graph
on the right plots the predicted long-term growth curves. (b) Growth dynamics in the presence of the wild-type virus Ad309, which was injected into
an established tumor. Both a slow model and a fast model were fitted. For the slow model, G=x/(x y
1/3+e). For the fast model, G=x/(x+y+e). Tumor
growth was assumed to be logistic, F=12(x+y)/W. For the slow model, different parameter combinations are shown that fit the data to a similar
degree (slow1, slow2). The graph on the right shows the predicted long term dynamics. Parameter values and root mean square values are given in
the Supporting Information S1.
doi:10.1371/journal.pone.0004271.g006
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different long term dynamics; within one model, different
parameter combinations that describe the data equally well can
give rise to different predictions regarding the long-term dynamics.
Our discussion of this and other results is postponed until the end
of this section.
Next consider experimental condition (ii), in which infected cells
were mixed with uninfected cells at a ratio of 1:1000 before the
tumor was injected into the mice. In this case, the viruses were
generally more effective. Tumor growth was prevented, and the
number of tumor cells declined to low levels. Figure 7 fits a slow
and a fast model to data that document infection with the wild
type virus Ad309 (Figure 7a) and the mutant virus Ad337
(Figure 7b). Consider the wild type As309 virus first (Figure 7a). All
models fit the data well. Again, the predictions about the long-
term dynamics vary, not only between models, but between
different parameter combinations of the same model. Two
qualitatively different outcomes are depicted in Figure 7a. On
the one hand, the cancer can grow out of control following the
initial reduction in the number of cancer cells. On the other hand,
the virus maintains control of the cancer, which persists but is
suppressed to relatively low levels. Thus, the encouraging but
limited trend shown by the data cannot be used to conclude
efficient virus-mediated tumor control. Longer experimental
studies are needed in order gain insights into the eventual
outcome of treatment, and to differentiate between the various
model predictions. Figure 7b shows the same analysis for the
mutant virus Ad337. As before, the slow and fast model can both
fit the data well, and within one model, different parameter
combinations are possible. The long-term dynamics show different
outcomes, depending on the model and the parameter combina-
tions. They include long term virus-mediated cancer control, as
well as uncontrolled cancer growth. In the context of the
experimental data, however, these long-term dynamics will not
be observed, as the cancers regressed completely in the
experiments. During the initial decline of the cancer cell
population in the model, the number of cells drops to such low
levels that extinction is actually the likely outcome in practical
terms. However, what this tells us is that if by chance the cancer
cell population does not hit extinction in the experiments, it is
entirely possible that the cancer cell population rebounds and
grows to high levels, depending on the model and its parameters.
As mentioned above, the experiments include both a highly
spatial setting where the virus was inoculated into an already
established tumor, and a mixed setting where infected and
uninfected cells were mixed before the tumor cells were placed
into the mouse. Therefore, it can be tempting to examine whether
the relative goodness of fit for the fast and slow models is different
in these two situations. As explained, however, each model can fit
the data with several alternative parameter combinations. There
are many more solutions to the least squares regression than
shown here. Therefore, it does not make sense to compare the
goodness of fit for slow and fast models. For instance if the fits
obtained for the slow model are slightly better than those obtained
for the fast model, it is quite possible that there exists another
parameter combination in the fast model that is better yet, and
that has not been encountered so far. This brings us to the
fundamental problem of nonlinear data fitting and model
validation, which is an interesting issue in itself and will be
discussed briefly here.
As with many (and perhaps most) other nonlinear models, the
parameter space where the minimization of the RMS error is
performed, is multidimensional and is characterized by many
shallow local minima. Most standard fitting routines get ‘‘stuck’’ at
local minima, and even more sophisticated algorithms aimed at
finding the global minimum are not very useful, because the
difference between the global minimum and many runner-ups is
usually insignificant and cannot serve as an indicator of the ‘‘right’’
Figure 7. (a) Data on the growth of A549 human lung cancer nude mouse xenografts in the presence of the wild-type virus Ad309, assuming that
infected and uninfected cells were mixed before the tumor cells were injected into the mouse [28]. A slow and a fast model were fitted. For each
model, different parameter combinations were found that fit the model comparably (slow1, slow2, fast1, fast2).The graph on the right side shows the
predicted long term dynamics for the different models and parameter combinations. (b) Infection with the mutant As337 virus, where again the
infected and uninfected cells were mixed before the tumor was injected into the mice. Again, a slow and a fast model were fitted, and with each
model different parameter combinations were found that provided a comparable fit to the data. As before, the graph on the right hand side shows
the predicted long-term dynamics. For the slow model, G=x/(x y
1/3+e). For the fast model, G=x/(x+y+e). Tumor growth was assumed to be logistic,
F=12(x+y)/W. Parameter values and root mean square values are given in the Supporting Information S1.
doi:10.1371/journal.pone.0004271.g007
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required to repeat the minimization procedure multiple times,
either by performing an exhaustive span of the space of the initial
guesses, or by implementing a Monte-Carlo method. The statistics
of the outcomes are then analyzed in the hope to find clusters of
good fits, which are then assumed to be indicative of the solution
of interest.
The unfortunate part is that most of the times, these
sophisticated statistical techniques are not very useful because
the data sets that the fitting is applied to are simply too sparse, and
they probably do not contain enough information to distinguish
between models. Some of the deficiencies of experimental data sets
are (i) an insufficient number of time-points, (ii) a very large
experimental error at each time point, due to the experimental
difficulties as well as a small sample size, and (iii) the long-term
dynamics is often not captured due to the time-constraints of the
experiment. In other words, no sophisticated statistical data
manipulation can help distinguish between models if the data set is
too sparse, short and contains large scatter.
What can we conclude from these considerations and our own
attempts to validate the models based on published experimental
data? The good news is that at least some of the models contain
parameter combinations which describe the existing data reason-
ably well. The bad news is that model validation/rejection was not
possible in the particular system that we used. If data were
collected over longer periods of time, and with a larger sample
size, then the number of parameter combinations that can fit the
data would be significantly reduced, and allow for more
meaningful model comparison.
Discussion
In this paper we presented the first modeling approach that tries
to analyze the dynamics of oncolytic viruses in a general setting,
going beyond particular models in which results can easily depend
on mathematical terms chosen. Previous approaches to modeling
oncolytic virus dynamics, and virus dynamics in general, have
been based on particular models that include uncertain and
unrealistic assumptions. The most striking is the assumption about
the infection term, which usually assumes perfect mixing of
populations, and which is certainly violated in any biologically
realistic setting.
Our method can be considered a hybrid between such space-
free, mass-action approaches, and much more complex methods
involving spatial network ideas, e.g. [29–36]. The former
approach fails to capture spatial and geometric constraints which
play an important role in infection spread. The latter approach is
only analytically tractable to a certain degree; also, it usually relies
on a particular, given, set of rules that govern the infection spread.
Our investigation aims to capture general trends that arise from
different assumptions on the infection mechanism. It combines the
analytical tractability of simple dynamical systems with a more
realistic modeling of infection spread.
We found that based on the infection term, we can divide
models into two categories with fundamentally different behavior.
In one group, virus growth is relatively fast because the infected
cells are dispersed among the uninfected cells rather than being
clustered together. In this case most infected cells contribute to
virus spread. In these models, there is a clear viral replication rate
threshold beyond which the number of cancer cells drops to levels
of the order of one or less, corresponding to extinction in practical
terms. Under this parameter region, this is the only outcome in
this class of model. In the other category, infected cells are
assumed to be clustered together to some degree in a mass, which
might be realistic for solid tumors. In this case, only the infected
cells located at the surface of the cluster contribute to virus spread
because they are in the vicinity of uninfected cells. The infected
cells located in the center of the cluster are surrounded only by
other infected cells and therefore do not contribute to virus
replication. The larger the number of infected cells, the smaller the
proportion of cells that can pass on the virus. In this scenario, virus
therapy is more difficult. If tumor growth saturates only at
relatively large sizes or does not saturate, then even in the
parameter regions where the dynamics can converge to tumor
control or eradication, there can be the possibility that the cancer
can outrun the virus if the number of cancer cells lies above a
threshold at the start of virus therapy. This is because of the
existence of the saddle node equilibrium which ensures depen-
dence of the outcome on initial conditions. This might be
problematic in clinical settings, because there is only a relatively
small window between the size at which the tumor becomes
detectable (about 10
10 cells) and the size at which it can induce
mortality (around 10
13 cells).Tumor growth saturation at lower
levels introduces a parameter region in which only the tumor
control outcome is possible. A further reduction in the number of
tumor cells at which growth saturation occurs can abolish the
existence of the saddle node equilibrium altogether. In this case,
the only outcome is tumor control. This result makes intuitive
sense: earlier saturation of tumor growth slows down the cancer,
and makes it easier for the virus to gain the upper hand. It also
means that if the tumor is found early, it might be possible to slow
down tumor growth by means of more conventional drug therapy,
enabling the virus to control the cancer and to prevent runaway
growth. There is indication in clinical data that a combination of
chemotherapy and oncolytic virus therapy leads to better results
than either approach alone [37].
Another important finding of our study is that the basic results
regarding the outcome of oncolytic virus therapy do not depend
on the particular tumor growth terms used in the model. The
exact kinetics of tumor growth are still poorly understood and a
source of uncertainty. We examined straight exponential growth,
as well as a number of more realistic options, including saturated
but continued growth at high numbers of cancer cells, as well as
cessation of growth as the number of tumor cells approaches an
upper limit. While there are minor differences (such as the
existence of a stable equilibrium at large tumor sizes vs continues
slow growth), the properties of the tumor control equilibrium are
largely independent from the exact way in which tumor growth is
modeled.
Throughout this paper we discussed the ability of the virus to
eradicate the tumor in the context of our mathematical model that
aims to describe oncolytic virus growth in relatively simple settings.
It is important to point out that even simple scenarios could be
characterized by complicating conditions which are not captured
in the model and which make actual tumor extinction difficult to
achieve. For example, tumor cells might become resistant to the
virus by for example down-regulating the receptor required for
viral entry [38]. Related to this, cells could temporarily become
resistant to virus-induced effects depending on the stage of the cell
cycle [39]. Such effects can be easily incorporated into our
framework, if data suggest that they play a role in determining the
dynamics of oncolytic virus growth.
The framework presented here aims to bring us closer towards
predictive computational models of oncolytic virus replication in
vitro. Both additional computational and experimental work will
be necessary to advance this framework. On the theoretical side, it
will be important to also explore spatially explicit and stochastic
models. The ordinary differential equations are desirable because
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straightforward way. At the same time, however, spatial aspects
of population growth can only be captured in a phenomenological
way. Hence, it will be important to consider a spatially explicit
model and to compare its properties to the results obtained here.
On the empirical side, it will be important to run experiments that
document the growth of specific oncolytic viruses e.g. in a culture
of specific tumor cells. These data can be fitted to the various
models explored here to determine which model describes the data
best and which models can be rejected. This can be done in a
variety of setting: a culture where cells and viruses can mix well; a
2D tissue culture which imposes a degree of spatial constraints;
and a 3D tissue culture which can impose further spatial
constraints. Different models will apply to these different scenarios.
This will allow us to test the theoretical notions presented here,
and to obtain a set of models that are predictive for the relevant
scenarios.
Of course, for clinical relevance, oncolytic virus replication
needs to be considered in the context of more complex settings.
Most importantly, the virus is immunogenic, and immune
responses can inhibit the spread of the virus and can even drive
it extinct. Such components will have to be incorporated into a
mathematical model that describes the replication of an oncolytic
virus in vivo. However, before we have obtained a solid
understanding of the principles that govern the dynamics of
oncolytic viruses in simpler settings, it is unlikely that modeling can
contribute much to understanding the more complicated in vivo
scenario. The modeling framework discussed here provides a basis
to incorporate increasing amounts of biological complexity in the
future, and thus to gradually improve our understanding of the key
factors that determine the outcome of oncolytic virus therapy.
Materials and Methods
The results described in this paper are based on the analysis of
ordinary differential equations. Extensive mathematical details are
provided in the Supporting Information S1.
Supporting Information
Supporting Information S1
Found at: doi:10.1371/journal.pone.0004271.s001 (0.11 MB
PDF)
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